期刊文献+

胱抑素C在急性冠脉综合征中的临床价值 被引量:3

The clinical value of cystatin C in acute Coronary Syndrome
下载PDF
导出
摘要 目的:探讨胱抑素C(cys C)在急性冠脉综合征(ACS)中的临床价值。方法:检测121例急性冠脉综合征患者血清胱抑素C水平,其中,急性心肌梗死(AMI)34例;不稳定心绞痛(UAP)48例;稳定性心绞痛(AP)39例,并比较13例ACS患者治疗前、后的胱抑素C浓度的变化。同时,选择20例非急性冠脉综合征患者做对照研究。结果:AMI组、UAP组胱抑素C水平显著高于对照组(P<0.001),AP组与对照组比较无统计学意义(P>0.05);AMI组显著高于AP组(P<0.001),但与UAP组比较无统计学意义(P>0.05);13例ACS患者治疗前、后的胱抑素C浓度比较有统计学意义(P<0.01)。结论:监测ACS患者血清胱抑素C水平对急性冠脉综合征的临床诊断、疗效评价和预后评估具有一定的价值。 Objective:To explore the clinical value of cystatin C in acute coronary syndrome.Methods: Detect the levels of serum cystatin C in 121patients with acute coronary syndrome,among them,AMI 34cases,UAP 48cases,AP 39cases.To compare the changes of serum cystatin C in 13 patients with ACS who accept the treatment or not.And the 20 patients who without ACS were chosen as control group.Results: The level of cystatin C in serum was remarkable higher in AMI and UAP than control group(P〈0.001),and it in AMI was higher than in AP either.In addition it was significant decrease in 13 ACS when they were treated(P〈0.01).Conclusion: There was certain value of detecting cystatin C in ACS patient’s serum in clinical diagnosis,response evaluation,prognosis assessment 更多
出处 《安徽卫生职业技术学院学报》 2011年第6期84-85,共2页 Journal of Anhui Health Vocational & Technical College
关键词 胱抑素C 急性冠脉综合征 临床价值 cystatin C; Acute Coronary Syndrome; clinical value; cystatin C; Acute Coronary Syndrome; clinical value; cystatin C Acute Coronary Syndrome clinical value
  • 相关文献

参考文献4

  • 1徐志强,王骏,王鸣和.胱抑素C与冠心病相关性的研究进展[J].心血管病学进展,2008,29(1):64-67. 被引量:36
  • 2Sekizuka H.Akashi YJ,Kawasaki K, et al.Cystain C: Abetter marker to detect coronary artery sclerosis [J]. Cardiol,2009,54(3):359-367.
  • 3KoeniW,TwardellaD,BrennerH,et al.Plasma con- centrations of cystatin C in patientswith coronary- heartdisease and risk forsecondary cardiovascu- larevents :more than simply amarker ofglomerular fil- tration rate[J]. ClinChem,2005, 51(2):321.
  • 4葛长江,任芳,吕树铮,柳弘,宋现涛,陈欣,孟康,吴小凡,苑飞,金泽宁,李红,季凤清.血浆胱抑素C对冠心病的临床预测价值[J].中华急诊医学杂志,2010,19(3):273-276. 被引量:45

二级参考文献18

  • 1J Am Coll Cardiol,张伟丽.CRP与斑块破裂有关[J].中国分子心脏病学杂志,2005,5(3):546-546. 被引量:78
  • 2徐峰,陈玉国,孙祎,李瑞建,刘春喜,陈文强,徐新生,张运.建立动脉粥样硬化蚀损斑块模型的实验研究[J].中华急诊医学杂志,2006,15(12):1085-1088. 被引量:2
  • 3Lindholt JS, Erlandsen E J, Henneberg EW. Cystatin C deficiency is associated with the progression of small abdominal aortic aneurysms [ J ]. Br J Surg, 2001, 88 : 1472-1475.
  • 4Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-nun mice[ J]. Circ Res, 2005,96 : 368 -375.
  • 5Yetkin E, Acikgoz N, Sivri N, et al, Increased plasma levels of cystatin C and transforming growth factor-betal in patients with coronary artery, ectasia: can there be a potential interaction between cystatin C and transforming growth factor-betal [ J ]. Coron Artery Dis ,2007,18 ( 3 ) :211-214.
  • 6Noto D,Cefalu'AB,Barbagallo CM,et al. Cystatin C levels are decreased in acute myocardial infarction:effect of cystatin C G73A gene polymorphism on plasma levels[J]. Int J Cardiol,2005,101(2) :213-217.
  • 7Luc G, Bard JM, Lesueur C. et al. Plasma cystatin-C and development of coronary heart disease : The PRIME Study [ J ]. Atheroselerosis, 2006,85 ( 2 ) : 375- 380.
  • 8Koeni W,Twardella D, Brenner H, et al. Plasma concentrations of eystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate [ J ]. Clin Chem ,2005,51 (2) :321-327.
  • 9Shlipak MG,Fried LF,Crump C,et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency [ J ]. Circulation, 2003,107:87-92.
  • 10Jemberg T, Lindahl B ,Jame S, et al. Cystatin C a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome[ J ]. Circulation,2004,110:2342-2348.

共引文献79

同被引文献27

  • 1Wichen D E,Gupta V J.Cysteine-homocysteine Mixed disulphide:differing plasma concentrations in normal men and women[J] .Clinical Science,1979,57 (2):211 - 215.
  • 2ARPEGARD J,OSTERGREN J,DEFAIRE U, Cystatin C a marker of peripheral at cherosclerotic disease [J].Atherosclerosis, 2008,199 : 397-401.
  • 3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J].Am J Cardiol,1983,51 (3):606.
  • 4Takeyabu K,Betsuyaku T,Nishimura M,et al. Cysteine pro- teinases and Cystatin C in bronchoalveolar lavage fluid from sub- jects with subclinical emphysema. Eur Respir J,1998,12 (2): 1033-1039.
  • 5Wang B, Sun J, Kitamoto S, et al.Cathepsin S controls angiogen- esis and tumor growth via matrik-derived angiogenic factors [J].J Biol Chem, 2006,281 (9) : 6020.
  • 6Shi GP,Sukhova GK,Grubb A,et al.Cystatin C deliciency in human athero sclerosis and aortic aneurysms [J].J C lin Invest, 1999,104: 1191.
  • 7SCHULTE S,SUN J,LIBBY P,et al. Cystatin C deficiency pro- motes inflammation in angiotensin II-induced abdominal aortic a- neurisms in atherosclerotic mice[J].Am I Pathol,2010, 177:456-463.
  • 8Weiss N,Zhang YY,Heydricks S,et al.Overexpression of cellu- lar glutathione peroxidase rescues homocyst (e)ine-induced en- dothelial dysfunction [J]. Proc Nat1 Acad Sci USA,2001,98: 12503-12508.
  • 9谭保平.急诊介入与溶栓治疗急性心肌梗死患者疗效对比分析[J].内科,2011,6(4):308-311. 被引量:17
  • 10席金瓯,王维鹏.循环酶法检测血清同型半胱氨酸的性能评价及临床应用[J].中国妇幼保健,2012,27(10):1574-1575. 被引量:6

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部